Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H27NO |
Molecular Weight | 285.4238 |
Optical Activity | ( + ) |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H]1[C@@H]2CC3=CC=C(O)C=C3[C@@]1(C)CCN2CC=C(C)C
InChI
InChIKey=VOKSWYLNZZRQPF-CCKFTAQKSA-N
InChI=1S/C19H27NO/c1-13(2)7-9-20-10-8-19(4)14(3)18(20)11-15-5-6-16(21)12-17(15)19/h5-7,12,14,18,21H,8-11H2,1-4H3/t14-,18+,19+/m1/s1
Molecular Formula | C19H27NO |
Molecular Weight | 285.4238 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q99720|||Q7Z653 Gene ID: 10280.0 Gene Symbol: SIGMAR1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/25559075 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 07:43:58 GMT 2023
by
admin
on
Sat Dec 16 07:43:58 GMT 2023
|
Record UNII |
A2G9VU2P2J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m8503
Created by
admin on Sat Dec 16 07:43:59 GMT 2023 , Edited by admin on Sat Dec 16 07:43:59 GMT 2023
|
PRIMARY | Merck Index | ||
|
A2G9VU2P2J
Created by
admin on Sat Dec 16 07:43:59 GMT 2023 , Edited by admin on Sat Dec 16 07:43:59 GMT 2023
|
PRIMARY | |||
|
7361-76-4
Created by
admin on Sat Dec 16 07:43:59 GMT 2023 , Edited by admin on Sat Dec 16 07:43:59 GMT 2023
|
PRIMARY | |||
|
12259685
Created by
admin on Sat Dec 16 07:43:59 GMT 2023 , Edited by admin on Sat Dec 16 07:43:59 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
||
|
TARGET -> AGONIST |
|
||
|
ENANTIOMER -> ENANTIOMER |
|
||
|
RACEMATE -> ENANTIOMER |
|